Assignee
ONYX PHARMA INC
US·52 granted patents·6 pending applications·1,934 citations·filing 1993–2022
Top patents by PatentIndex Score
58 records- 0197US5846945ACytopathic viruses for therapy and prophylaxis of neoplasiaONYX PHARMA INC·Filed 1995·Granted Dec 8, 1998·235 cites·5 claims
- 0297US5677178ACytopathic viruses for therapy and prophylaxis of neoplasiaONYX PHARMA INC·Filed 1996·Granted Oct 14, 1997·227 cites·29 claims
- 0395US6723316B2Herpes simplex virus-1 Glycoprotein C mutants for treating unwanted hyperproliferative cell growthONYX PHARMA INC·Filed 2000·Granted Apr 20, 2004·71 cites·10 claims
- 0494US6225060B1Baculovirus expression system and method for high throughput expression of genetic materialONYX PHARMA INC·Filed 1999·Granted May 1, 2001·218 cites·22 claims
- 0594US5801029ACytopathic viruses for therapy and prophylaxis of neoplasiaONYX PHARMA INC·Filed 1995·Granted Sep 1, 1998·126 cites·23 claims
- 0694US5525490AReverse two-hybrid methodONYX PHARMA INC·Filed 1994·Granted Jun 11, 1996·201 cites·12 claims
- 0792US7001596B1Oncolytic adenovirusONYX PHARMA INC·Filed 2000·Granted Feb 21, 2006·45 cites·11 claims
- 0891US6428960B1Selection method for producing recombinant baculovirusONYX PHARMA INC·Filed 2000·Granted Aug 6, 2002·127 cites·15 claims
- 0990US5856181ACytopathic viruses for therapy and prophylaxis of neoplasiaONYX PHARMA INC·Filed 1997·Granted Jan 5, 1999·71 cites·4 claims
- 1088US7307071B2RAF-MEK-ERK pathway inhibitors to treat cancerONYX PHARMA INC·Filed 2002·Granted Dec 11, 2007·31 cites·8 claims
- 1184US2022267372A1Compounds for proteasome enzyme inhibitionONYX PHARMA INC·Filed 2022·Application pending·0 cites
- 1283US6635244B2Adenovirus E1B-55K single amino acid mutants and methods of useONYX PHARMA INC·Filed 2001·Granted Oct 21, 2003·11 cites·7 claims
- 1382US5539085ABcl-2 and R-ras complexONYX PHARMA INC·Filed 1993·Granted Jul 23, 1996·62 cites·6 claims
- 1481US7396679B2Oncolytic adenovirusONYX PHARMA INC·Filed 2002·Granted Jul 8, 2008·9 cites·16 claims
- 1581US7078030B2Oncolytic adenovirusONYX PHARMA INC·Filed 2003·Granted Jul 18, 2006·21 cites·9 claims
- 1680US5597719AInteraction of RAF-1 and 14-3-3 proteinsONYX PHARMA INC·Filed 1994·Granted Jan 28, 1997·105 cites·6 claims
- 1779US7442534B2Nucleic acids and polypeptides which resemble Rho and which interact with cell signalling pathways and proteinsONYX PHARMA INC·Filed 2002·Granted Oct 28, 2008·5 cites·14 claims
- 1879US6013464AHuman PAK65ONYX PHARMA INC·Filed 1997·Granted Jan 11, 2000·34 cites·17 claims
- 1979US5518911AHuman PAK65ONYX PHARMA INC·Filed 1995·Granted May 21, 1996·32 cites·12 claims
- 2076US2020325172A1Compounds for proteasome enzyme inhibitionONYX PHARMA INC·Filed 2020·Application pending·0 cites
- 2174US6379665B1Phospholipase D polypeptide and DNA sequencesONYX PHARMA INC·Filed 2000·Granted Apr 30, 2002·6 cites·11 claims
- 2274US5698445AHuman PAK65ONYX PHARMA INC·Filed 1996·Granted Dec 16, 1997·25 cites·15 claims
- 2372US7994294B2Nucleic acids and polypeptides related to a guanine exchange factor of Rho GTPaseONYX PHARMA INC·Filed 2006·Granted Aug 9, 2011·1 cites·8 claims
- 2469US6569655B2Nucleic acids and polypeptides related to a guanine exchange factor of Rho GTPaseONYX PHARMA INC·Filed 2001·Granted May 27, 2003·2 cites·6 claims
- 2568US7785887B2Adenovirus E1B-55K single amino acid mutants and methods of useONYX PHARMA INC·Filed 2003·Granted Aug 31, 2010·1 cites·15 claims
- 2668US6296845B1Selective killing and diagnosis of p53+ neoplastic cellsONYX PHARMA INC·Filed 1998·Granted Oct 2, 2001·31 cites·12 claims
- 2768US5756669AP53-binding polypeptides and polynucleotides encoding sameONYX PHARMA INC·Filed 1995·Granted May 26, 1998·36 cites·15 claims
- 2866US7556955B2Nucleic acids encoding Candida kefyr cytosine deaminaseONYX PHARMA INC·Filed 2006·Granted Jul 7, 2009·0 cites·17 claims
- 2965US12076363B2Peptide epoxyketone proteasome inhibitors in combination with PIM kinase inhibitors for treatment of cancersONYX PHARMA INC·Filed 2021·Granted Sep 3, 2024·0 cites·16 claims
- 3065US6017763AG-beta-gamma regulated phosphatidylinositol-3' kinaseONYX PHARMA INC·Filed 1999·Granted Jan 25, 2000·14 cites·25 claims
- 3164US6500653B1Nucleic acids and polypeptides which resemble RHO and which interact with cell signaling pathways and proteinsONYX PHARMA INC·Filed 1999·Granted Dec 31, 2002·12 cites·13 claims
- 3264US5948643AModulators of BRCA1 activityONYX PHARMA INC·Filed 1997·Granted Sep 7, 1999·18 cites·7 claims
- 3363US7141404B2Candida kefyr cytosine deaminaseONYX PHARMA INC·Filed 2003·Granted Nov 28, 2006·0 cites·8 claims
- 3463US6762284B1Nucleotide sequences that encode phosphatidylinositol-3′ kinase associated proteins and uses thereofONYX PHARMA INC·Filed 2000·Granted Jul 13, 2004·2 cites·3 claims
- 3563US5705342AInteraction of BCL-2 and R-RASONYX PHARMA INC·Filed 1995·Granted Jan 6, 1998·15 cites·10 claims
- 3662US6660259B2Herpes simplex virus for treating unwanted hyperproliferative cell growthONYX PHARMA INC·Filed 2000·Granted Dec 9, 2003·1 cites·15 claims
- 3762US6133243ALiposomal-viral DNA complexes for treating diseaseONYX PHARMA INC·Filed 1996·Granted Oct 17, 2000·17 cites·10 claims
- 3861US7148002B2Nucleic acids and polypeptides related to a guanine exchange factor of Rho GTPaseONYX PHARMA INC·Filed 2003·Granted Dec 12, 2006·0 cites·14 claims
- 3961US5698428AHuman PAK65ONYX PHARMA INC·Filed 1997·Granted Dec 16, 1997·12 cites·37 claims
- 4060US6133419ANucleotide sequences that encode phosphatidylinositol-3' kinase associated proteins and uses thereofONYX PHARMA INC·Filed 1997·Granted Oct 17, 2000·16 cites·7 claims
- 4159US7414113B2Antibody that specifically binds to Candida kefyr Cytosine deaminaseONYX PHARMA INC·Filed 2006·Granted Aug 19, 2008·0 cites·8 claims
- 4258US5605825AHuman PAK65ONYX PHARMA INC·Filed 1995·Granted Feb 25, 1997·10 cites·29 claims
- 4357US6080578ACytopathic adenoviral E1B mutated viruses for therapy and prophylaxis of neoplasiaONYX PHARMA INC·Filed 1997·Granted Jun 27, 2000·24 cites·10 claims
- 4457US2021338766A1Methods of treating multiple myelomaONYX PHARMA INC·Filed 2021·Application pending·0 cites
- 4555US7829329B2Adenoviral vectors for treating diseaseONYX PHARMA INC·Filed 2002·Granted Nov 9, 2010·0 cites·8 claims
- 4655US6764674B1Adenovirus E1B shuttle vectorsONYX PHARMA INC·Filed 1999·Granted Jul 20, 2004·11 cites·14 claims
- 4754US6238881B1Nucleic acids and polypeptides related to a guanine exchange factor of Rho GTPaseONYX PHARMA INC·Filed 1997·Granted May 29, 2001·12 cites·13 claims
- 4849US5876711AMethods and compositions for determining the tumor suppressor status of cellsONYX PHARMA INC·Filed 1996·Granted Mar 2, 1999·10 cites·7 claims
- 4948US6511825B1Cell signaling polypeptides and nucleic acidsONYX PHARMA INC·Filed 1999·Granted Jan 28, 2003·11 cites·11 claims
- 5048US2005003507A1Method for purifying virusONYX PHARMA INC·Filed 2004·Application pending·0 cites
Showing the top 50 of 58 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when ONYX PHARMA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →